Cook Wealth’s Checkpoint Therapeutics CKPT Stock Holding History

Cook Wealth’s Portfolio CKPT Stock Details CKPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-1,556	Closed	–	–	45
2022 Q2	$0	Hold	1,556	–	–	﹤0.01%	46
2022 Q1	$0	Buy	+1,556	New	+$33.4K	﹤0.01%	40

Other funds holding CKPT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JSMC

Jess S. Morgan & Co Los Angeles, California $115M AUM 16.65% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

BBA

Baader Bank Aktiengesellschaft Unterschleissheim, Germany $1.33B AUM 47.35% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

SAG

Spotlight Asset Group Oakbrook Terrace, Illinois $143M AUM 20.66% 1-Year Est. Return

Millennium Management New York $276B AUM 44.8% 1-Year Est. Return

PAM

PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

Cook Wealth's CKPT Position: Q3 2022 in Review

Cook Wealth sold out of Checkpoint Therapeutics (CKPT) in Q3 2022, closing a stake of 1,556 shares.

Cook Wealth first reported a position in CKPT in Q1 2022 and held it in 2 quarters. The position peaked at $0 in Q2 2022. 57 funds tracked by Wall St. Rank hold CKPT as of Q3 2022.

Cook Wealth reported no remaining Checkpoint Therapeutics position as of Q3 2022 after selling out during the quarter.
Cook Wealth sold 1,556 Checkpoint Therapeutics shares in Q3 2022.
Cook Wealth first reported a position in Checkpoint Therapeutics in Q1 2022 and held it in 2 quarters.
Cook Wealth's Checkpoint Therapeutics position peaked at $0 in Q2 2022.
57 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2022.

Based on Cook Wealth's 13F filing for Q3 2022, filed 14 Nov 2022.